Register Login

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Position paper

Blood Transfusion - 4 2022 (July-August)

Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET)

Authors

Francesco Paciullo , Emanuele Valeriani , Angelo Porfidia , Marcello Di Nisio , Marco P. Donadini , Rossella Marcucci , Domenico Prisco , Carlo Cagini , Paolo Gresele , Walter Ageno

Key words: anticoagulant agents, antiplatelet agents, evidence-based medicine, retinal vein occlusion
DOI: 10.2450/2022.0276-21
Publication Date: 2022-01-21

Abstract

Retinal vein occlusion (RVO) represents a common cause of visual impairment and blindness. RVO may be associated with both local (e.g., hyperopia, glaucoma) and systemic (e.g., hypertension, diabetes, smoking, obesity, and dyslipidaemia) risk factors. The association with thrombophilia remains controversial. Data on the use of antithrombotic therapy for RVO are poor and inconsistent with most of the information being derived from observational studies. Here we provide a position statement from the Italian Society on Thrombosis and Haemostasis (SISET) to guide the clinical and therapeutic management of patients with RVO based on the available evidence and expert opinion.

Downloads

PDF
Authors

Francesco Paciullo - Division of Internal and Cardiovascular Medicine, Department of Medicine and Surgery, University of Perugia, Perugia, Italy

Emanuele Valeriani - Diagnostic and Therapeutic Medicine Department, University Campus Bio-Medico of Rome, Rome, Italy

Angelo Porfidia - Department of Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

Marcello Di Nisio - Department of Medicine and Ageing Sciences, University G. D’Annunzio, Chieti-Pescara, Italy

Marco P. Donadini - Department of Medicine and Surgery, University of Insubria, Varese, Italy

Rossella Marcucci - Department of Experimental and Clinical Medicine, "Careggi" University Hospital, University of Florence, Florence, Italy

Domenico Prisco - Department of Experimental and Clinical Medicine, "Careggi" University Hospital, University of Florence, Florence, Italy

Carlo Cagini - Department of Medicine and Surgery, Section of Ophthalmology, University of Perugia, Perugia, Italy

Paolo Gresele - Division of Internal and Cardiovascular Medicine, Department of Medicine and Surgery, University of Perugia, Perugia, Italy

Walter Ageno - Department of Medicine and Surgery, University of Insubria, Varese, Italy

  • Abstract viewed - 476 times
  • PDF downloaded - 316 times